Bristol Myers Squibb Reports Officer Changes, Compensation Arrangements
Ticker: CELG-RI · Form: 8-K · Filed: Feb 15, 2024 · CIK: 14272
| Field | Detail |
|---|---|
| Company | Bristol Myers Squibb Co (CELG-RI) |
| Form Type | 8-K |
| Filed Date | Feb 15, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, compensation, 8-K, corporate-governance
TL;DR
**Bristol Myers Squibb filed an 8-K on February 15, 2024, detailing officer changes and compensation arrangements effective February 13, 2024.**
AI Summary
Bristol-Myers Squibb Company filed an 8-K on February 15, 2024, reporting events that occurred on February 13, 2024. The filing indicates changes related to the departure, election, or appointment of certain officers, as well as compensatory arrangements for these officers. Specific names of individuals or detailed dollar amounts of compensation were not provided in the excerpt.
Why It Matters
Changes in executive leadership and their compensation can signal shifts in company strategy, operational focus, or financial outlook, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in executive leadership and compensation can influence company direction and investor confidence, but the specific impact depends on the individuals involved and the nature of the arrangements, which are not detailed in this filing excerpt.
Key Players & Entities
- BRISTOL-MYERS SQUIBB COMPANY (company) — registrant
- Delaware (location) — state of incorporation
- Princeton, NJ (location) — business address
- 03 Life Sciences (company) — organization name related to filer
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 13, 2024.
What types of events were reported under Item 5.02?
Item 5.02 reported the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers.
What is the exact name of the registrant company?
The exact name of the registrant company is BRISTOL-MYERS SQUIBB COMPANY.
When was this 8-K filed with the SEC?
This 8-K was filed with the SEC on February 15, 2024.
What is the registrant's state of incorporation?
The registrant's state of incorporation is Delaware.
Filing Stats: 655 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2024-02-15 16:57:39
Key Financial Figures
- $0.10 — nge on which registered Common Stock, $0.10 Par Value BMY New York Stock Exchan
Filing Documents
- ef20021804_8k.htm (8-K) — 38KB
- 0001140361-24-008198.txt ( ) — 221KB
- bmy-20240213.xsd (EX-101.SCH) — 5KB
- bmy-20240213_def.xml (EX-101.DEF) — 18KB
- bmy-20240213_lab.xml (EX-101.LAB) — 28KB
- bmy-20240213_pre.xml (EX-101.PRE) — 20KB
- ef20021804_8k_htm.xml (XML) — 8KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Effective February 15, 2024, Mr. Phil Holzer will be appointed Senior Vice President and Controller of Bristol-Myers Squibb Company (the "Company"). Ms. Sharon Greenlees, Senior Vice President and Controller, will assume another role at the Company, effective February 15, 2024. Mr. Holzer, 48, joined the Company in 2001. Most recently, from 2021 to 2024, he served as Senior Vice President, Finance, Treasury and Tax Operations. Prior to that, he served in multiple roles of increasing responsibility, including Senior Vice President, Enterprise Integrations from 2019 to 2021, Vice President and Head of Finance, Research & Development from 2018 to 2019, Chief Audit Officer from 2015 to 2018, and Vice President, U.S. Commercialization Finance from 2013 to 2015. Mr. Holzer has a Bachelor of Science degree in Accounting from The University of Tampa and is a Certified Public Accountant. Mr. Holzer is not a party to any arrangement or understanding regarding his selection as an officer. There are no family relationships between Mr. Holzer and any director or executive officer of the Company. Mr. Holzer is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits The following exhibits are furnished as part of this Current Report on Form 8-K: Exhibit No. Description 104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101). EXHIBIT INDEX Exhibit No. Description 104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRISTOL-MYERS SQUIBB COMPANY Dated: February 15, 2024 By: /s/ Kimberly M. Jablonski Name: Kimberly M. Jablonski Title: Corporate Secretary